TSLA
Tesla
-- 423.330 NVDA
NVIDIA
-- 136.390 PLTR
Palantir
-- 78.218 RGTI
Rigetti Computing
-- 11.4799 AMD
Advanced Micro Devices
-- 125.180 
"Integrated Innovation, Stepping into the Future" - 2024 Seminar on Approaching Morimatsu Wraps Up
MORIMATSU OPEN DAY
Seminar on Approaching Morimatsu
Integrated Innovation, Stepping into the Future
On October 17, the "Integrated Innovation, Stepping into the Future" - 2024 Seminar on Approaching Morimatsu was held by Morimatsu LifeSciences in Changshu Manufacturing Base.
Highlights
At this conference, invited industry experts shared their experience with Morimatsu experts. Professionals from the production, R&D, procurement, quality control and other positions of pharmaceutical and biopharmaceutical enterprises, as well as nearly 100 guests from the Service of Societies of "Innovation China" & Alumni Association of the Biomedical Industry at East China University of Science and Technology participated in the event to exchange and discuss the future development trend of the biomedical industry. We would like to express our special thanks to our friendly sponsors, Jiangsu GeneIII Biotechnology Co., Ltd. and WeCare Probiotics (Suzhou) Co., Ltd., for their strong support of this event.
Keynote speech
The booming development trend is evident in the biopharmaceutical industry, driven by the wave of new technologies and influenced by diversified demands and application scenarios. Mr. Gao Yang, Deputy General Manager of Shanghai Morimatsu Biotechnology Co., Ltd., presided over the conference, and five guests brought wonderful topics.
First of all, Mr. Jiang Pei, Senior Vice President of Morimatsu LifeSciences, delivered a speech and introduced Changshu Plant; Prof. Guo Meijin from East China University of Science and Technology, Mr. Duan Zhiguang, Chief Technology Officer of Giant Biogene, Mr. Zhou Xinhua, Chief Scientific Officer of Biometa/CEO of Bainuo Yintai, Mr. He Guolun, Deputy General Manager and Mr. Wan Xun, Technical Director of Morimatsu Biotechnology, have explored hot topics and trends in the industry around intelligent biofabrication technology, biofabrication and application research of recombinant collagen, the power of artificial intelligence to miRNA pharmaceutical platforms, and design considerations for full-scale magnified bioreactors, they clash ideas and share insights through discussion and exchange; at the same time, the latest achievements and solutions of Morimatsu in the field of biomedicine were also showcased to the public.
From these sharing, the participants not only mastered the cutting-edge news and future trends of biomedical technology, but also drew rich inspiration and wisdom, so that the new mind for future research directions and innovation paths have been broaden, and the process of innovation and practical application of biomedical technology has been accelerated.
Workshop&Exhibition Hall Visit
After the discussion, the attending guests went to visit the workshop. Entering this modern factory that integrates automation, intelligence, and sustainability, they gained a more intuitive understanding of the strength in R&D, manufacturing, process technology, and quality control of Morimatsu.
After the visit, the guests came to the exhibition hall to learn more about the corporate philosophy, development history and technological achievements of Morimatsu.
The event aims to build an open exchange platform to promote the sharing of knowledge, technology and resources. Thanks to this platform, Morimatsu has an opportunity to further listen to the demands of customers and turn these valuable suggestions into an inexhaustible driving force for technological innovation and service optimization, thus creating more value. And also, Morimatsu hopes to better help the high-quality development of biomedical industry and make more impressive and positive contributions to the cause of human health!
About Morimatsu LifeSciences
Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligence integrated plant solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular plant solutions and services.
As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacturing plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.
Forward-Looking Statements
The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of “predicted”, “believed”, “forecast”, “planned” and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.
Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment